Atara Biotherapeutics, Inc. (ATRA)
6.69
+0.19
(+2.92%)
USD |
NASDAQ |
Nov 18, 16:00
6.69
0.00 (0.00%)
After-Hours: 20:00
Atara Biotherapeutics Price : 6.69 for Nov. 18, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 17, 2026 | 6.40 | 7.02 | 5.975 | 6.50 | 71804.00 |
| Nov 16, 2026 | 7.50 | 7.55 | 6.275 | 6.40 | 45296.00 |
| Nov 13, 2026 | 7.63 | 7.795 | 7.46 | 7.70 | 17042.00 |
| Nov 12, 2026 | 8.37 | 8.41 | 7.695 | 7.93 | 16693.00 |
| Nov 11, 2026 | 8.10 | 8.37 | 7.94 | 8.23 | 10340.00 |
| Nov 10, 2026 | 8.03 | 8.375 | 7.800 | 8.10 | 33145.00 |
| Nov 09, 2026 | 7.87 | 8.314 | 7.693 | 8.18 | 13696.00 |
| Nov 06, 2026 | 7.86 | 8.00 | 7.74 | 7.87 | 16300.00 |
| Nov 05, 2026 | 8.36 | 8.36 | 7.47 | 7.96 | 29548.00 |
| Nov 04, 2026 | 8.25 | 8.525 | 8.25 | 8.37 | 9481.00 |
| Nov 03, 2026 | 8.34 | 8.65 | 8.17 | 8.20 | 17248.00 |
| Nov 02, 2026 | 8.05 | 8.59 | 8.02 | 8.48 | 32050.00 |
| Oct 30, 2026 | 8.53 | 8.53 | 7.723 | 8.01 | 29961.00 |
| Oct 29, 2026 | 8.73 | 8.84 | 8.260 | 8.53 | 11873.00 |
| Oct 28, 2026 | 8.25 | 8.66 | 8.220 | 8.66 | 26854.00 |
| Oct 27, 2026 | 8.44 | 8.57 | 8.14 | 8.30 | 21699.00 |
| Oct 26, 2026 | 8.68 | 8.68 | 8.10 | 8.35 | 35268.00 |
| Oct 23, 2026 | 9.37 | 9.37 | 8.55 | 8.59 | 24320.00 |
| Oct 22, 2026 | 9.23 | 9.65 | 8.971 | 9.43 | 23018.00 |
| Oct 21, 2026 | 9.25 | 9.43 | 9.17 | 9.35 | 26543.00 |
| Oct 20, 2026 | 8.89 | 9.29 | 8.88 | 9.16 | 14846.00 |
| Oct 19, 2026 | 9.03 | 9.35 | 8.96 | 8.96 | 12450.00 |
| Oct 16, 2026 | 9.67 | 9.905 | 9.18 | 9.18 | 19493.00 |
| Oct 15, 2026 | 9.35 | 9.78 | 9.185 | 9.65 | 24451.00 |
| Oct 14, 2026 | 9.29 | 9.990 | 9.20 | 9.56 | 39955.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 17.84 |
| Alnylam Pharmaceuticals, Inc. | 149.48 |
| Anika Therapeutics, Inc. | 13.62 |
| Savara, Inc. | 4.735 |
| Arrowhead Pharmaceuticals, Inc. | 43.12 |
Price Related Metrics
| PS Ratio | 21.83 |
| Earnings Yield | -18.33% |
| Market Cap | 68.16M |